Skip to main content

MANGOCEUTICALS, INC.

corporate_fare Company Profile

MANGOCEUTICALS, INC.

MGRX·NASDAQ·Industrial Applications And Services·CIK 0001938046

Mangoceuticals, Inc. develops, markets, and sells men's wellness products and services in the United States, primarily through a telemedicine platform. The company offers erectile dysfunction products under the Mango brand, hair loss products under the Grow brand, hormone balance and therapy products under the Mojo brand, and weight loss products under the Slim brand. It also provides oral testosterone undecanoate, marketed under the Prime brand, to treat low testosterone in men and for testosterone replacement therapy. Mangoceuticals facilitates customer access to a licensed pharmacy for online fulfillment and distribution of medications prescribed during telehealth consultations. The company markets and sells its products online via its website, www.MangoRX.com. Incorporated in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as a subsidiary of Cohen Enterprises, Inc.

MANGOCEUTICALS, INC. (NASDAQ:MGRX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors MGRX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Mangoceuticals Raises $272K in Private Placement at Deep Discount
  • Mangoceuticals Reports Severe Cash Drain, Reiterates Going Concern, Faces Nasdaq Delisting, and Discloses Controversial CEO Subsidiary Agreement
  • MANGOCEUTICALS Faces Delisting Amid Soaring Losses, CEO Option Repricing, and Related Party Control of Core Assets
  • Mangoceuticals Reprices CEO Options, Files $73M Lawsuit Against Former Consultant
  • Mangoceuticals Sues Former Tech Firm for $73M+ Over Failed Platform Delivery

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$456.02K
Net Income
-$20.64M
Diluted EPS
-$2.17
Op. Cash Flow
-$5.85M
Gross Profit
$250.39K
Operating Income
-$18.03M
Cash & Equivalents
$1.49M
Debt / Equity
0.00×
Net Margin
-45.27×
Shares Outstanding
15.89M sh
Source: 10-K · filed 2026-04-01 · accession 0001493152-26-014478

Dilution Risk

Low risk

Filing-implied dilution signals for MGRX, detected from its recent SEC filings · latest filing 2026-07-02.

2 shelf registrations

Private Placement Completed · Deep Discount Pricing

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with M →
$0.465 -0.00% today
52-week range · as of 2026-07-02 $0.162 – $2.75
Market cap
$8.07M
Volume
1.1M (0.6× avg)
3-mo avg 1.8M
Live data · 2026-07-05 02:07 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MGRX - Latest Insights

MGRX
Jul 02, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4555
Real-time Price: $0.465 info
Change: +$0.0095 (+2%) info
Market Cap: $8.069M info
MGRX
May 19, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4299
Real-time Price: $0.465 info
Change: +$0.0351 (+8%) info
Market Cap: $8.069M info
MGRX
Apr 01, 2026, 6:31 AM EDT
Filing Type: 10-K
Importance Score:
10
Price at Filing: $0.3622
Real-time Price: $0.465 info
Change: +$0.1028 (+28%) info
Market Cap: $8.069M info
MGRX
Mar 17, 2026, 4:00 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4005
Real-time Price: $0.465 info
Change: +$0.0645 (+16%) info
Market Cap: $8.069M info
MGRX
Mar 17, 2026, 4:00 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.4676
Real-time Price: $0.465 info
Change: -$0.0026 (-0.56%) info
Market Cap: $8.069M info
MGRX
Mar 06, 2026, 4:02 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.520
Real-time Price: $0.465 info
Change: -$0.055 (-11%) info
Market Cap: $8.069M info
MGRX
Feb 23, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4855
Real-time Price: $0.465 info
Change: -$0.0205 (-4%) info
Market Cap: $8.069M info
MGRX
Feb 19, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4966
Real-time Price: $0.465 info
Change: -$0.0316 (-6%) info
Market Cap: $8.069M info
MGRX
Feb 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.382
Real-time Price: $0.465 info
Change: +$0.083 (+22%) info
Market Cap: $8.069M info
MGRX
Jan 23, 2026, 5:07 PM EST
Filing Type: S-1/A
Importance Score:
9
Price at Filing: $0.5383
Real-time Price: $0.465 info
Change: -$0.0733 (-14%) info
Market Cap: $8.069M info
MGRX
Jan 13, 2026, 5:30 PM EST
Filing Type: S-1
Importance Score:
9
Price at Filing: $0.7202
Real-time Price: $0.465 info
Change: -$0.2552 (-35%) info
Market Cap: $8.069M info